84
Participants
Start Date
March 5, 2025
Primary Completion Date
February 5, 2027
Study Completion Date
February 5, 2028
NALIRIFOX
Patient in upfront surgery arm will receive operation followed by adjuvant chemotherapy with NALIRIFOX; patient in experimental arm will receive neoadjuvant NALIRIFOX followed by operation than adjuvant NALIRIFOX after operation.
RECRUITING
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
RECRUITING
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
RECRUITING
China Medical University Hospital, Taichung
RECRUITING
Taichung Veterans General Hospital, Taichung
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Tri-Service General Hospital, Taipei
RECRUITING
Linkou Chang Gung Memorial Hospital, Taoyuan District
National Cheng-Kung University Hospital
OTHER
Chang Gung Memorial Hospital
OTHER
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
National Taiwan University Hospital
OTHER
China Medical University Hospital
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Tri-Service General Hospital
OTHER
Taichung Veterans General Hospital
OTHER